Wirz Stefan, Schenk Michael, Kieselbach Kristin
Abteilung für Anästhesie, Interdisziplinäre Intensivmedizin, Schmerzmedizin/Palliativmedizin - Zentrum für Schmerzmedizin, Weaningzentrum, Cura Krankenhaus - eine Betriebsstätte der GFO Kliniken Bonn, Schülgenstr. 15, 53604, Bad Honnef, Deutschland.
Zentrum für Integrative Schmerzmedizin, Franziskus-Krankenhaus Berlin, Budapester Str. 15, 10787, Berlin, Deutschland.
Schmerz. 2022 Aug;36(4):293-307. doi: 10.1007/s00482-022-00655-9. Epub 2022 Jul 13.
Androgen insufficiency under treatment with opioids, antidepressants and anticonvulsants in chronic pain diseases is a side effect with a high prevalence. It can lead to clinical metabolic alterations, adynamia, stress intolerance, anemia or osteoporosis and has a significant impact on the quality of life. Opioids, antidepressants and anticonvulsants affect the hypothalamic-pituitary-gonadal axis of sex hormones. A urologist, andrologist or endocrinologist should be involved in the treatment at an early stage. The recommendation of a differential therapeutic selection of certain substances is only indicative and does not meet evidential criteria. The indications for androgen substitution must be individualized and in consideration of the risk-benefit profile. Awareness of this side effect of an otherwise lege artis medicinal pain therapy must be sharpened and compulsory included in the differential diagnostic considerations.
慢性疼痛疾病患者在使用阿片类药物、抗抑郁药和抗惊厥药治疗过程中出现雄激素不足是一种普遍的副作用。它可导致临床代谢改变、乏力、应激不耐受、贫血或骨质疏松,对生活质量有重大影响。阿片类药物、抗抑郁药和抗惊厥药会影响下丘脑 - 垂体 - 性腺轴的性激素。泌尿外科医生、男科医生或内分泌科医生应在早期参与治疗。关于某些药物的差异化治疗选择的建议仅具有指示性,不符合循证标准。雄激素替代的适应症必须个体化,并考虑风险 - 效益情况。必须提高对这种原本合理用药的疼痛治疗副作用的认识,并将其强制纳入鉴别诊断考虑因素中。